Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 65.5 NOK 1.24%
Market Cap: 1.8B NOK

Relative Value

The Relative Value of one PHO stock under the Base Case scenario is hidden NOK. Compared to the current market price of 65.5 NOK, Photocure ASA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHO Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
53
vs Industry
39
Median 3Y
3.1
Median 5Y
3.5
Industry
2.6
Forward
3
vs History
vs Industry
1
Median 3Y
-32
Median 5Y
-31.7
Industry
21.6
Forward
43.7
vs History
46
vs Industry
22
Median 3Y
30.1
Median 5Y
36.7
Industry
16.5
vs History
vs Industry
8
Median 3Y
-38.3
Median 5Y
-35.2
Industry
22.5
vs History
50
vs Industry
24
Median 3Y
3.2
Median 5Y
3.7
Industry
2.3
vs History
53
vs Industry
44
Median 3Y
2.6
Median 5Y
3
Industry
2.9
Forward
2.6
vs History
53
vs Industry
64
Median 3Y
2.8
Median 5Y
3.2
Industry
5.5
vs History
31
vs Industry
15
Median 3Y
25
Median 5Y
27.1
Industry
13
Forward
21.5
vs History
0
vs Industry
6
Median 3Y
33.9
Median 5Y
26.2
Industry
16.6
Forward
25.2
vs History
47
vs Industry
27
Median 3Y
24.3
Median 5Y
31.3
Industry
15.8
vs History
28
vs Industry
23
Median 3Y
30.9
Median 5Y
29.3
Industry
19.1
vs History
49
vs Industry
25
Median 3Y
3
Median 5Y
3.5
Industry
1.9

Multiples Across Competitors

PHO Competitors Multiples
Photocure ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Photocure ASA
OSE:PHO
1.7B NOK 3.3 -327 50 1 714.5
US
Eli Lilly and Co
NYSE:LLY
997.2B USD 16.8 54.2 36.3 39
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
503.6B USD 5.5 20 16.4 21.3
CH
Roche Holding AG
SIX:ROG
251.4B CHF 4.1 26.7 11.4 13.3
UK
AstraZeneca PLC
LSE:AZN
211.3B GBP 4.9 30.2 108.7 159.1
CH
Novartis AG
SIX:NOVN
206.9B CHF 4.6 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
244.4B USD 3.8 12.8 9.2 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.1 9.1 10.6
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
145.2B USD 2.3 14.8 7.5 10.3
P/E Multiple
Earnings Growth PEG
NO
Photocure ASA
OSE:PHO
Average P/E: 23.7
Negative Multiple: -327
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.7
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
12.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NO
Photocure ASA
OSE:PHO
Average EV/EBITDA: 403.4
50
46%
1.1
US
Eli Lilly and Co
NYSE:LLY
36.3
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.4
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.1
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NO
Photocure ASA
OSE:PHO
Average EV/EBIT: 1 866
1 714.5
81%
21.2
US
Eli Lilly and Co
NYSE:LLY
39
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
1%
10.6
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3